Poland
· Delayed Price · Currency is PLN Dr.Finance Statistics
Total Valuation
Dr.Finance has a market cap or net worth of PLN 2.09 million. The enterprise value is 1.76 million.
| Market Cap | 2.09M |
| Enterprise Value | 1.76M |
Important Dates
The last earnings date was Tuesday, February 11, 2025.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Dr.Finance has 3.74 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 3.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 45.16% |
| Owned by Institutions (%) | n/a |
| Float | 1.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 6.98 |
| P/TBV Ratio | 6.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.93 |
| EV / Sales | 0.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.76 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -106.06 |
Financial Efficiency
Return on equity (ROE) is -58.45% and return on invested capital (ROIC) is -26.76%.
| Return on Equity (ROE) | -58.45% |
| Return on Assets (ROA) | -13.16% |
| Return on Invested Capital (ROIC) | -26.76% |
| Return on Capital Employed (ROCE) | -63.61% |
| Revenue Per Employee | 5.13M |
| Profits Per Employee | -127,200 |
| Employee Count | 2 |
| Asset Turnover | 11.31 |
| Inventory Turnover | 0.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.92% in the last 52 weeks. The beta is 1.43, so Dr.Finance's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -51.92% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 48.84 |
| Average Volume (20 Days) | 6,359 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr.Finance had revenue of PLN 10.25 million and -254,400 in losses. Loss per share was -0.07.
| Revenue | 10.25M |
| Gross Profit | 9.82M |
| Operating Income | -190,900 |
| Pretax Income | -254,400 |
| Net Income | -254,400 |
| EBITDA | -189,000 |
| EBIT | -190,900 |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 351,400 in cash and 21,300 in debt, giving a net cash position of 330,100 or 0.09 per share.
| Cash & Cash Equivalents | 351,400 |
| Total Debt | 21,300 |
| Net Cash | 330,100 |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 300,100 |
| Book Value Per Share | 0.08 |
| Working Capital | 299,400 |
Cash Flow
| Operating Cash Flow | 52,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 95.77%, with operating and profit margins of -1.86% and -2.48%.
| Gross Margin | 95.77% |
| Operating Margin | -1.86% |
| Pretax Margin | -2.48% |
| Profit Margin | -2.48% |
| EBITDA Margin | -1.84% |
| EBIT Margin | -1.86% |
| FCF Margin | n/a |
Dividends & Yields
Dr.Finance does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -12.15% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 1, 2016. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jul 1, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |